Nephrogenic systemic fibrosis

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Nephrogenic systemic fibrosis.php on line 2
Nephrogenic systemic fibrosis

LE WE PMID CA

Nephrogenic systemic fibrosis

1931

Nephrogene systemische Fibrose

Liver (MRT)

Nephrogenic systemic fibrosis

Scleredema

Sclerodermia

Scleromyxedema

Shulman s syndrome Eosinophilic fasciitis

Skin (Fibrosis)

2008 1	Gadolinium and nephrogenic systemic fibrosis: the evidence of things not seen. [18290354] Cleve Clin J Med 75(2): 112, 114, 117 (2008)
2008 2	Nephrogenic systemic fibrosis and its association with gadolinium exposure during MRI. [18290353] Cleve Clin J Med 75(2): 95-7, 103-4, 106 passim (2008)
2007 3	Nephrogenic fibrosing dermopathy: report of two cases. [17989891] Acta Derm Venereol 87(6): 521-4 (2007)
2006 4	Nephrogenic fibrosing dermopathy: case report and review. [16638421] Dermatol Online J 12(3): 7 (2006)
2009 5	Current status of gadolinium toxicity in patients with kidney disease. [19201920] Clin J Am Soc Nephrol 4(2): 461-9 (2009)
2007 6	Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link? [17699407] Clin J Am Soc Nephrol 2(2): 200-2 (2007)
2010 7	Nephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices. [20299369] Clin J Am Soc Nephrol 5(6): 964-71 (2010)
2004 8	Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure. [14736976] Nephrol Dial Transplant 19(2): 469-73 (2004)
2007 9	Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders. [17907160] Arthritis Rheum 56(10): 3173-5 (2007)
2008 10	How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease? [18385396] Clin J Am Soc Nephrol 3(3): 649-51 (2008)
2007 11	New insights into nephrogenic systemic fibrosis. [17855637] J Am Soc Nephrol 18(10): 2636-43 (2007)
2007 12	Nephrogenic systemic fibrosis--the need for a multidisciplinary approach. [17617650] Nephrol Dial Transplant 22(11): 3097-101 (2007)
2008 13	MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis. [18806155] AJR Am J Roentgenol 191(4): 1129-39 (2008)
2008 14	Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. [18356456] AJR Am J Roentgenol 190(4): 1060-8 (2008)
2007 15	Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. [17242272] AJR Am J Roentgenol 188(2): 586-92 (2007)
2009 16	Nephrogenic systemic fibrosis and its impact on abdominal imaging. [19959508] Radiographics 29(6): 1565-74 (2009)
2010 17	Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases. [20413447] Br J Radiol 83(991): 590-5 (2010)
2007 18	Nephrogenic systemic fibrosis: risk factors and incidence estimation. [17267695] Radiology 243(1): 148-57 (2007)
2007 19	Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. [17213364] Radiology 242(3): 647-9 (2007)
2009 20	Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities. [19789233] Radiology 253(3): 689-96 (2009)
2009 21	Features of nephrogenic systemic fibrosis on radiology examinations. [19542396] AJR Am J Roentgenol 193(1): 61-9 (2009)
2009 22	Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis. [18952698] Nephrol Dial Transplant 24(3): 856-63 (2009)
2007 23	The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy--report of two cases and review of the literature. [17124282] Nephrol Dial Transplant 22(2): 631-6 (2007)
2009 24	Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases. [19188312] Radiology 250(2): 371-7 (2009)
2009 25	Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients. [19709997] Radiology 253(1): 81-9 (2009)
2008 26	Nephrogenic systemic fibrosis: a chemical perspective. [18487530] Radiology 247(3): 608-12 (2008)
2008 27	Gadolinium chelate-associated nephrogenic systemic fibrosis. [18362996] Singapore Med J 49(3): 181-5 (2008)
2009 28	Nephrogenic systemic fibrosis: mini-review. [19488616] Clinics (Sao Paulo) 64(5): 482-4 (2009)
2010 29	Nephrogenic systemic fibrosis: a concise review for cardiologists. [20978560] Tex Heart Inst J 37(5): 508-15 (2010)
2008 30	Gadolinium and nephrogenic systemic fibrosis: time to tighten practice. [17943276] Pediatr Radiol 38(5): 489-96; quiz 602-3 (2008)
2010 31	Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data. [21179310] World J Radiol 2(11): 427-33 (2010)
2008 32	Scleroderma-like fibrosing disorders. [18329541] Rheum Dis Clin North Am 34(1): 199-220; ix (2008)
2006 33	Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide. [17061066] Eur Radiol 16(12): 2619-21 (2006)
2009 34	Nephrogenic systemic fibrosis in liver disease: a systematic review. [19937937] J Magn Reson Imaging 30(6): 1313-22 (2009)
2006 35	Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. [16461069] Semin Arthritis Rheum 35(4): 238-49 (2006)
2010 36	Nephrogenic systemic fibrosis. [21283650] F1000 Med Rep 2(-): 84 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Nephrogenic systemic fibrosis.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Nephrogenic systemic fibrosis.php on line 92